A meta-analysis of 11 randomized trials included 485 healthy adults without coronary heart disease. Algal-oil DHA lowered triglycerides by about 0.20 mmol/L on average at a median dose of 1.68 grams per day. It also raised HDL cholesterol and LDL cholesterol. Because the participants were healthy and the intervention was algal DHA, the result should not be extended automatically to severe hypertriglyceridemia or mixed fish-oil products.

EPA and DHA are long-chain omega-3 fats. They become part of cell membranes and help form signaling molecules involved in cardiovascular, immune, and other functions. These established biological roles help explain why omega-3s can affect blood lipids, but they do not prove that a supplement

The 2024 meta-analysis found lower relative risks of coronary revascularization, heart attack, and cardiovascular death among adults assigned to EPA or EPA plus DHA. The pooled relative differences were about 10% for revascularization, 11% for heart attack, and 8% for cardiovascular death. These percentages do not reveal an individual’s absolute benefit, which depends heavily on baseline risk.

Results were stronger in EPA-only trials than in trials combining EPA and DHA. That pattern is informative but does not prove that EPA alone is superior for every person or outcome. The studies also differed in prevention setting, formulation, and follow-up, and results

DHA is abundant in the brain, making cognitive effects biologically plausible. Human outcomes are less certain. A network meta-analysis of randomized trials in healthy older adults and adults with mild cognitive impairment found domain-specific signals for DHA, including memory and processing speed, but did not establish universal cognitive enhancement.

Some rankings were sensitive to study duration, sample size, and participant characteristics. The findings therefore do not justify promising better memory to healthy adults. The review excluded people with diagnosed dementia, so it does not show that omega-3 supplements treat dementia.[6]

A product’s total fish-oil weight is not the same as its EPA-plus-DHA content. Chemical form can also change short-term absorption. In a randomized crossover study of eight women, free-fatty-acid forms produced higher blood levels than triglyceride forms, while ethyl esters produced lower levels. Free fatty acids were less well tolerated, and belching was the main reported side effect.

The formulation story is not settled. A separate meal study in five adults with normal lipid levels found no meaningful difference in omega-3 absorption responses between ethyl esters and triglycerides when equivalent amounts of fat were provided. Both studies were

A meta-analysis of 11 randomized trials included 485 healthy adults without coronary heart disease. Algal-oil DHA lowered triglycerides by about 0.20 mmol/L on average at a median dose of 1.68 grams per day. It also raised HDL cholesterol and LDL cholesterol. Because the participants were healthy and the intervention was algal DHA, the result should not be extended automatically to severe hypertriglyceridemia or mixed fish-oil products.

EPA and DHA are long-chain omega-3 fats. They become part of cell membranes and help form signaling molecules involved in cardiovascular, immune, and other functions. These established biological roles help explain why omega-3s can affect blood lipids, but they do not prove that a supplement

The 2024 meta-analysis found lower relative risks of coronary revascularization, heart attack, and cardiovascular death among adults assigned to EPA or EPA plus DHA. The pooled relative differences were about 10% for revascularization, 11% for heart attack, and 8% for cardiovascular death. These percentages do not reveal an individual’s absolute benefit, which depends heavily on baseline risk.

Results were stronger in EPA-only trials than in trials combining EPA and DHA. That pattern is informative but does not prove that EPA alone is superior for every person or outcome. The studies also differed in prevention setting, formulation, and follow-up, and results

DHA is abundant in the brain, making cognitive effects biologically plausible. Human outcomes are less certain. A network meta-analysis of randomized trials in healthy older adults and adults with mild cognitive impairment found domain-specific signals for DHA, including memory and processing speed, but did not establish universal cognitive enhancement.

Some rankings were sensitive to study duration, sample size, and participant characteristics. The findings therefore do not justify promising better memory to healthy adults. The review excluded people with diagnosed dementia, so it does not show that omega-3 supplements treat dementia.[6]

A product’s total fish-oil weight is not the same as its EPA-plus-DHA content. Chemical form can also change short-term absorption. In a randomized crossover study of eight women, free-fatty-acid forms produced higher blood levels than triglyceride forms, while ethyl esters produced lower levels. Free fatty acids were less well tolerated, and belching was the main reported side effect.

The formulation story is not settled. A separate meal study in five adults with normal lipid levels found no meaningful difference in omega-3 absorption responses between ethyl esters and triglycerides when equivalent amounts of fat were provided. Both studies were